Tenon Medical TNON Cash Flow Statement (2021-2026)

NASDAQ TNON
$2.44 -0.92 (-27.38%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Tenon Medical Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Tenon Medical reported cash from operations of -$2.76M and free cash flow of -$2.93M for the quarter ended Jun 2026, down 24.6% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.36M-2.84M-2.35M-5.54M-3.26M-7.92M-4.89M-4.32M-3.38M-3.16M-3.57M-3.84M-3.21M-3.17M-3.68M-2.86M-3.39M-2.87M-3.46M-4.21M
Share-based CompensationStock Comp.
0.44M0.41M0.17M0.55M1.03M1.14M1.04M1.05M0.10M0.98M1.02M1.03M0.91M0.88M0.87M0.42M0.09M0.34M0.54M0.41M
Gains from Investment SecuritiesGains Investment
0.04M-0.13M
Asset Writedowns and ImpairmentWritedown
0.01M0.04M-0.01M0.01M-0.01M
Cash from OperationsCash from Ops.
-1.41M-1.69M-2.46M-2.76M-3.41M-3.38M-3.58M-3.18M-3.15M-2.28M-2.34M-2.42M-2.34M-2.78M-2.48M-2.21M-3.82M-2.22M-2.96M-2.76M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.07M0.07M0.07M0.07M0.18M0.85M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.01M0.02M0.02M0.03M0.03M0.04M0.05M0.09M0.10M0.09M0.10M0.12M0.04M0.05M0.08M0.10M0.09M0.06M
Change in Working Capital
Change in ReceivablesChange Receivables
0.06M0.01M-0.01M0.01M0.07M0.08M0.09M0.28M0.17M-0.26M0.06M0.14M0.20M-0.02M0.02M-0.12M0.54M0.40M0.28M-0.03M
Change in InventoryChange Inventory
-0.00M0.17M0.41M0.03M0.18M-0.40M0.00M0.15M-0.10M0.08M0.08M-0.02M-0.00M-0.00M-0.01M0.08M0.48M-0.17M-0.25M-0.28M
Change in Account PayablesChange Payables
-0.06M0.20M-0.05M-0.08M0.08M0.13M0.38M-0.02M-0.15M-0.33M-0.17M0.84M-0.02M-0.72M0.13M0.40M-0.26M0.22M-0.20M-0.02M
Change in Accured ExpensesChange Accured Exp.
0.17M0.26M-0.12M0.69M-1.05M2.77M-0.01M0.70M-0.78M-0.02M0.39M-0.01M-0.24M-0.31M0.09M0.06M0.50M0.01M0.08M0.07M
Investing Activities
Capital ExpendituresCapex
0.02M0.08M0.13M0.04M0.08M0.60M0.08M0.13M0.06M0.09M0.12M0.10M-0.04M-0.11M0.19M0.06M0.17M
Change in Acquisitions & DivestmentsChange Acquisitions
4.40M3.67M4.75M1.75M0.49M
Cash from Investing ActivitiesCash from Investing
-7.88M3.38M4.28M-8.18M-1.32M2.34M4.67M1.13M0.44M-0.09M-0.12M-0.10M0.04M-0.64M-0.19M-0.06M-0.17M
Financing Activities
Other financing activitiesOther financing
-0.07M-3.49M
Cash from Financing ActivitiesCash from Financing
3.79M-0.18M-0.05M14.19M-0.03M-0.04M4.71M0.27M1.37M4.37M9.64M0.11M6.26M-0.06M0.06M2.73M3.87M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.02M0.00M0.01M0.01M625.000.01M125.00
Net Equity Issued and RepurchasedNet Equity Issued
-4.36M0.04M2.60M4.01M
Additional items
Exchange Rate EffectFX Effect
0.00M0.00M-0.05M0.01M0.05M-0.00M0.01M-0.03M0.06M0.05M
Change in Cash
-5.50M1.51M1.76M3.20M-4.72M-1.02M1.05M2.67M-2.48M-0.94M1.96M-2.42M7.19M-2.63M3.78M-2.46M-4.40M0.31M0.85M-2.93M
Free Cash FlowFCF
-1.43M-1.77M-2.59M-2.80M-3.49M-3.99M-3.66M-3.30M-3.21M-2.37M-2.46M-2.42M-2.45M-2.74M-2.48M-2.21M-3.71M-2.42M-3.02M-2.93M
Net Cash FlowNCF
-5.50M1.51M1.76M3.25M-4.73M-1.07M1.05M2.66M-2.45M-1.00M1.91M-2.42M7.19M-2.63M3.78M-2.27M-4.40M0.31M0.85M-2.93M